SBIR Phase I: Novel Particulate Fluidization Systems for Pulmonary Drug Delivery Applications

Information

  • NSF Award
  • 0215073
Owner
  • Award Id
    0215073
  • Award Effective Date
    7/1/2002 - 22 years ago
  • Award Expiration Date
    12/31/2002 - 22 years ago
  • Award Amount
    $ 99,993.00
  • Award Instrument
    Standard Grant

SBIR Phase I: Novel Particulate Fluidization Systems for Pulmonary Drug Delivery Applications

0215073<br/>Singh<br/><br/>This Small Business Innovation Research project proposes to develop novel fluidization systems that are needed for synthesis of nano-encapsulated insulin particles for pulmonary drug delivery applications. By coating the insulin particle with very thin (10-50 nm) layer of biodegradable polymers such as polylactic acid (PLA), the sustained release characteristics of insulin can be significantly altered. The unique method has several advantages over conventional methods including low polymer loading, and impurity-free processing. The nano-encapsulation method involves using laser ablation thin film deposition technique to coat drug particles which are fluidized in the gas phase. This Phase I project will develop batch scale fluidization systems which are capable of fluidizing up to 1 kg of particles at a time.<br/><br/>The commercial applications of this project are in the area of pharmaceutical drug delivery.

  • Program Officer
    Om P. Sahai
  • Min Amd Letter Date
    6/11/2002 - 22 years ago
  • Max Amd Letter Date
    6/11/2002 - 22 years ago
  • ARRA Amount

Institutions

  • Name
    SINMAT, INC.
  • City
    GAINESVILLE
  • State
    FL
  • Country
    United States
  • Address
    1912 NW 67th Place
  • Postal Code
    326531649
  • Phone Number
    3523347237

Investigators

  • First Name
    Deepika
  • Last Name
    Singh
  • Email Address
    singh@sinmat.com
  • Start Date
    6/11/2002 12:00:00 AM

FOA Information

  • Name
    Health
  • Code
    203000